These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1647602)

  • 1. [S-phase fraction of benign mastopathies and breast carcinomas].
    Kunz J; Winzer KJ
    Zentralbl Chir; 1991; 116(7):483-6. PubMed ID: 1647602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
    Kunz J
    Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpalpable breast lesions: wire localization and excisional biopsy.
    Proudfoot RW; Mattingly SS; Stelling CB; Fine JG
    Am Surg; 1986 Mar; 52(3):117-22. PubMed ID: 3006562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical evidence of vimentin in fibrocystic breast disease and mammary carcinoma].
    Alexiev B; Valkov I; Popov A
    Zentralbl Pathol; 1992 Sep; 138(4):284-8. PubMed ID: 1329942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland].
    Guski H; Hufnagl P; Freitag A; Winzer KJ
    Gegenbaurs Morphol Jahrb; 1989; 135(1):39-53. PubMed ID: 2544475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
    Lin L; Pathmanathan N
    Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of hyperelastosis in proliferative lesions of the breast].
    Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
    Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment for intraductal proliferative lesions].
    Kimijima I; Abe R; Ohuchi N; Akimoto M
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1406-9. PubMed ID: 2555665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 17. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.
    McDivitt RW; Stone KR; Craig RB; Meyer JS
    Lab Invest; 1985 Mar; 52(3):287-91. PubMed ID: 2983150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.